Search
Search
Close this search box.
Search
Close this search box.

gastroparesis

New Ozempic Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects

Product Liability / July 25, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , ,

A growing number of individuals who have turned to Ozempic to manage their blood sugar levels or shed unwanted weight are now facing a new and debilitating challenge – severe stomach paralysis, also known as gastroparesis. As more and more people file lawsuits against the drug’s manufacturer, Novo Nordisk, a disturbing pattern has emerged, with […]

New Ozempic Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects Read More »

Ozempic and Wegovy Linked to Severe Vision Loss in New Study

Product Liability / July 15, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , , , ,

The popular diabetes and weight loss medications Ozempic and Wegovy, both containing the active ingredient semaglutide, have been hailed as revolutionary treatments in recent years. However, a new semaglutide study published this month in the medical journal JAMA Ophthalmology has uncovered a troubling connection between these popular drugs and a debilitating eye condition called nonarteritic

Ozempic and Wegovy Linked to Severe Vision Loss in New Study Read More »

Study Finds Side Effects of GLP-1 Drugs Could Cause Bone Density Loss

Product Liability / July 5, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , ,

A troubling new study has uncovered another potential side effect of Ozempic, Wegovy, Mounjaro, and other popular glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. According to researchers, these in-demand treatments may be linked to a significant reduction in bone mineral density (BMD), potentially putting users at risk of osteoporosis and fractures. As the medical community

Study Finds Side Effects of GLP-1 Drugs Could Cause Bone Density Loss Read More »

New Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects of Wegovy

Product Liability / July 5, 2024 / 4 minutes of reading / By / , , , , , , , , , , ,

Wegovy, a higher-dose version of the widely used diabetes drug Ozempic, has gained significant popularity in recent years as a weight-loss aid. However, a growing number of individuals across the United States are now pursuing legal action against the manufacturer, Novo Nordisk, alleging that the company failed to adequately warn about the potential risks associated

New Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects of Wegovy Read More »

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries

Product Liability / May 17, 2024 / 4 minutes of reading / By / , , , , , , , , , , ,

Despite the growing popularity of Novo Nordisk’s semaglutide-based Wegovy as a solution for weight loss, an alarming number of Wegovy users have reported severe gastrointestinal complications, including a debilitating condition known as gastroparesis. As patients struggle with the life-altering effects of gastroparesis, or stomach paralysis, many are considering legal claims, seeking compensation and accountability from

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries Read More »

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems

Product Liability / April 26, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , ,

An Iowa man has taken legal action against the manufacturers of Ozempic, a widely prescribed diabetes drug. In a product liability lawsuit filed last week in the U.S. District Court for the Northern District of Iowa, plaintiff Shawn Derrick alleges that Novo Nordisk and its subsidiaries failed to provide adequate warnings about the health risks

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems Read More »

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate?

Product Liability / April 22, 2024 / 4 minutes of reading / By / , , , , , , , , , , ,

In recent years, millions of Americans have turned to medications like Ozempic, Wegovy, and Mounjaro, which belong to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), for weight loss and diabetes management. These drugs have been aggressively promoted by their manufacturers as safe and effective. However, a growing number of former

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate? Read More »

Ozempic Use Led to Gastrointestinal Side Effects, Gallbladder Removal: Lawsuit

Product Liability / April 5, 2024 / 4 minutes of reading / By / , , , , , , , , , ,

A lawsuit filed late last month in the U.S. District Court for the Eastern District of Pennsylvania sheds light on the potential severity of the gastrointestinal side effects allegedly linked to the popular diabetes and weight-loss drug Ozempic. The lawsuit was filed by Miquana Renteria, a Texas woman who alleges that Ozempic manufacturer Novo Nordisk

Ozempic Use Led to Gastrointestinal Side Effects, Gallbladder Removal: Lawsuit Read More »

Lawsuit Against Ozempic, Trulicity Manufacturers Alleges Gastroparesis Side Effects

Product Liability / March 11, 2024 / 4 minutes of reading / By / , , , , , , , ,

A Pennsylvania woman has taken legal action against the manufacturers of Ozempic and Trulicity, alleging that she suffered severe and painful injuries, including bowel obstruction and severe nausea, as a result of gastroparesis side effects linked to these diabetes drugs. Danielle Kindrew filed a product liability lawsuit against Novo Nordisk and Eli Lilly, the makers

Lawsuit Against Ozempic, Trulicity Manufacturers Alleges Gastroparesis Side Effects Read More »

Wegovy and Ozempic Lawsuits: The Risk of Stomach Paralysis Side Effects

Product Liability / January 16, 2024 / 5 minutes of reading / By / , , , , , , , , ,

Drug manufacturer Novo Nordisk faces a growing number of lawsuits accusing the company of failing to warn users about the potential risk of stomach paralysis or gastroparesis associated with Ozempic and its sister drug Wegovy. The use of medications like Wegovy and even Ozempic for weight loss has become increasingly popular due to evidence that

Wegovy and Ozempic Lawsuits: The Risk of Stomach Paralysis Side Effects Read More »

Scroll to Top